Intrinsic Value

Vallon Pharmaceuticals, Inc. (VLON)


-0.06 (-13.04%)

Enterprise Value -
Net Debt -3.78
Equity Value -
Shares Outstanding 10.14
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt